Chapter 6

*Nanocrystalline Materials*

Nashville; 2005. p. T2217

[19] Moneghini M, Carcano A, Zingone G, Perissutti B. Studies in dissolution enhancement of atenolol. International Journal of Pharmaceutics.

[20] Anwar M, Warsi MH,

Sciences. 2011;**44**:241-249

[21] Mummaneni V, Dressman JB, Amidon GL. Gastric pH influences the appearance of double peaks in the plasma concentration-time profiles of cimetidine aster administration in dogs. Pharmaceutical Research.

[22] Vergote GJ, Vervaet C, Van Driessche I, Hoste S, De Smedt S, Demeester J, et al. In-vivo evaluation

of matrix pellets containing nanocrystalline ketoprofen.

International Journal of Pharmaceutics.

1998;**175**:177-183

1995;**12**:780-786

2002;**240**:79-84

pressure homogenization (HPH) versus ball milling. AAPS Annual Meeting.

[18] Singh A, Deep A. Formulation and evaluation of nanoparticles containing atenolol. International Journal of Pharmaceutical Research. 2011;**3**:59-62

Mallick N, Akhter S, Gahoi S, Jain GK, et al. Enhanced bioavailability of nanosized chitosan-atorvastatin conjugate after oral administration to rats. European Journal of Pharmaceutical

**88**
